Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Department of Justice DOJ

DOJ alleges Kaiser Permanente defrauded Medicare of $1 billion

Kaiser maintains it has done nothing wrong and said it plans to "strongly" defend against lawsuits alleging otherwise.

FDA hopes new guidance will prove ‘one of the most significant public health nutrition interventions in a generation’

Aimed at food manufacturers, chain restaurants and food service operators, the document offers target sodium levels for some 163 categories of processed, prepared and packaged foods.

Telemedicine has improved access to healthcare

Healthcare access has improved thanks to advances and higher adoption of telemedicine.

 

Thumbnail

AMA releases 2022 updates to medical coding

The American Medical Association has released its 2022 updates to the Current Procedural Terminology (CPT) code set.

 

Thumbnail

Healthcare orgs given extra time to comply with price transparency

The Biden administration has given healthcare organizations extra time to comply with a price transparency rule.

 

Thumbnail

$4.1B savings for Medicare thanks to shared savings program

Medicare’s Shared Savings Program (MSSP) saw its best financial performance in 2020, with 513 participating ACOs saving the CMS more than $4 billion gross and almost $2 billion net. 

Thumbnail

More than 2.5M gained health coverage during special open enrollment

A special enrollment period implemented by the Biden administration saw more than 2.5 million people sign up for health insurance.

 

Thumbnail

Medicare improves racial healthcare inequities

Medicare is associated with reductions in racial and ethnic disparities in insurance coverage, access to care and self-reported health across the U.S., according to a new study published in JAMA.

 

Displaying 681 - 688 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup